ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 2 for:    hart acr16
Previous Study | Return to List | Next Study

A Study of Pridopidine (ACR16) for the Treatment of Patients With Huntington's Disease (HART)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00724048
Recruitment Status : Completed
First Posted : July 29, 2008
Last Update Posted : July 22, 2016
Sponsor:
Information provided by (Responsible Party):
Teva Pharmaceutical Industries

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2011
  Actual Study Completion Date : June 2011
  Certification/Extension First Submitted : February 19, 2013